TrialJournal of radiation research2019

Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non-small-cell lung cancer.

Tomohiro Itonaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.